Innovative inhaler available worldwide
Researchers at the University of Groningen have developed an innovative dry powder inhaler for asthma and COPD treatment. This new inhaler, the Novolizer, has many advantages over existing inhalers. The Novolizer is a good example of what the Centre for Valorization and Entrepreneurship wants to achieve.
The weekly online video magazine Unifocus highlights topics related to the University of Groningen in the fields of research and society, student life, teaching, policy and internationalization.
| Last modified: | 13 March 2020 4.32 p.m. |
More news
-
05 February 2021
Smoking during pregnancy affects the pulmonary health of future grandchildren
If a woman smokes during pregnancy, there is a higher risk that her future grandchildren will have lung problems and asthma. These are the findings of a study carried out by researchers at the University Medical Center Groningen (UMCG) among 37,000...
-
03 February 2021
Mental health at lowest ebb since the start of the coronavirus pandemic
Our quality of life is now the worst it has been since the start of the coronavirus pandemic: people in the Northern Netherlands currently give their life a score of 6.9. Last summer, this was 7.7 and at the start of the pandemic, it was 7.4. In...
-
26 January 2021
Study into the effect of COVID-19 vaccines in vulnerable groups
UMCG researchers to study the effect of COVID-19 vaccines on kidney, lung transplant and cancer patients. For this, they will be granted approx. 7.2 million Euro from ZonMw.